Microsoft publicly bans employees from using DeepSeek for the first time
Brad Smith, Vice Chair and President of Microsoft, stated at a U.S. Senate hearing that an internal ban has been issued prohibiting all employees from using the DeepSeek application (including desktop/mobile versions). Although DeepSeek is an open-source model that companies can deploy themselves to prevent data backflow, Microsoft pointed out that it still poses risks of "spreading propaganda content or generating unsafe code." It is noteworthy that Microsoft has not completely banned competing products (such as Perplexity) in the Windows App Store, but Google-related applications (including Gemini) have quietly disappeared. (TechCrunch)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.


